Since high expression of CD73 induces immunosuppressive microenvironment in iCCA (SUN B Y et al. 2023) and anti-PD-1 therapy combined with other therapies such as Gem/Cis chemotherapy represents an effective treatment strategy for iCCA. This evidence concerns the gene PDCD1 and infantile convulsions and choreoathetosis.